• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

ClearPoint Neuro

ClearPoint Neuro secures $110M investment

May 13, 2025 By Sean Whooley

ClearPoint Neuro (Nasdaq:CLPT) announced today that it entered into a note financing agreement with Oberland Capital Management of up to $110 million. The agreement includes $30 million in gross proceeds at closing. Oberland agreed to provide an additional $25 million at the option of the company at any time prior to Dec. 31, 2026. It […]

Filed Under: Business/Financial News, Featured, Imaging, MassDevice Earnings Roundup, Neurological, Neuromodulation/Neurostimulation Tagged With: ClearPoint Neuro

ClearPoint Neuro launches new navigation software

April 25, 2025 By Sean Whooley

ClearPoint Neuro (Nasdaq:CLPT) announced that it kicked off the full-market launch of its latest navigation software. Solana Beach, California-based ClearPoint Neuro said it commenced the full-market release of its ClearPoint Navigation Software Version 3.0. The new software introduces a new iCT image-guidance workflow option performed in a traditional operating room. ClearPoint Neuro’s new software builds […]

Filed Under: Imaging, Neurological, Surgical Tagged With: ClearPoint Neuro

ClearPoint Neuro wins FDA clearance for neuro laser therapy accessory

April 29, 2024 By Sean Whooley

ClearPoint Neuro (Nasdaq:CLPT) announced today that the FDA granted 510(k) clearance for its Prism bone anchor accessory. It marks the second new product introduction in 2024 for the company, with its stereotactic guidance system garnering clearance in January. The Prism system features the only non-cooled laser applicator on the market, the company said. Its next-generation laser applicator […]

Filed Under: News Well Tagged With: ClearPoint Neuro

ClearPoint Neuro reports positive laser therapy results

March 11, 2024 By Sean Whooley

ClearPoint Neuro (Nasdaq:CLPT) today announced preclinical results highlighting the accuracy of its Prism neuro laser therapy system. The Prism system features the only non-cooled laser applicator on the market, the company said. Its next-generation laser applicator technology eliminates the need for external cooling. This simplifies setup, reduces power and ablation time and lessens imaging artifact […]

Filed Under: Clinical Trials, Neurological Tagged With: ClearPoint Neuro

ClearPoint Neuro prices $15M offering

February 29, 2024 By Sean Whooley

ClearPoint Neuro (Nasdaq:CLPT) announced today that it priced an underwritten public offering worth approximately $15 million. The company is offering 2,307,694 shares of its common stock at a price to the public of $6.50 per share. It also granted the underwriter a 30-day option to purchase up to an additional 346,154 shares of common stock […]

Filed Under: Business/Financial News, Funding Roundup, Neurological, Neuromodulation/Neurostimulation Tagged With: ClearPoint Neuro

New ClearPoint Neuro software wins FDA clearance, used in first cases

February 22, 2024 By Sean Whooley

ClearPoint Neuro (Nasdaq:CLPT) announced that the FDA cleared its ClearPoint 2.2 software with integrated Maestro Brain Modeling. The Solana Beach, California-based company also reported the first-in-human cases following the FDA clearance. ClearPoint Neuro President and CEO Joe Burnett said the system now offers fast, peri-procedural segmentation of the cortical structures of the brain. This helps […]

Filed Under: Business/Financial News, Health Technology, Imaging, Neurological, Software / IT Tagged With: ClearPoint Neuro, FDA

ClearPoint Neuro reports first procedures with laser therapy system

January 25, 2024 By Sean Whooley

ClearPoint Neuro (Nasdaq:CLPT) announced that it completed the first procedures with its laser therapy and navigation systems. In September 2022, the FDA cleared the company’s Swedish partner Clinical Laserthermia Systems’ neuro laser therapy system. The Solana Beach, California-based company planned from then to commercialize the system as the Prism. ClearPoint Neuro holds exclusive global rights […]

Filed Under: Neurological Tagged With: ClearPoint Neuro

FDA clears stereotactic guidance system from ClearPoint Neuro

January 16, 2024 By Sean Whooley

ClearPoint Neuro (Nasdaq:CLPT) announced today that it received FDA 510(k) clearance for its SmartFrame OR stereotactic system. Solana Beach, California–based ClearPoint Neuro developed its SmartFrame OR system with two main components. It features the SmartFrame OR technology with the ClearPointer optical navigation wand. SmartFrame OR offers stereotactic guidance for placing and operating instruments or devices […]

Filed Under: 510(k), Food & Drug Administration (FDA), Health Technology, Imaging, Neurological, News Well, Regulatory/Compliance, Surgical Tagged With: ClearPoint Neuro, FDA

ClearPoint Neuro enters drug delivery licensing deal with UCB

May 24, 2023 By Sean Whooley

ClearPoint Neuro (Nasdaq:CLPT) announced today that it entered into a multi-year license agreement with UCB over gene therapy delivery. Solana Beach, California-based ClearPoint Neuro develops a therapy-enabling platform providing navigation and delivery to the brain. The licensing agreement with UCB establishes a partnership on delivery platforms for UCB’s gene therapy portfolio. Get the full story […]

Filed Under: Business/Financial News, Drug-Device Combinations, Neurological Tagged With: ClearPoint Neuro, UCB

ClearPoint Neuro expects at least 22% revenue growth in 2023

January 11, 2023 By Sean Whooley

ClearPoint Neuro (Nasdaq:CLPT) today announced preliminary fourth-quarter revenues that came up short of Wall Street projections. Solana Beach, California-based ClearPoint Neuro expects $5.2 million in sales for the quarter ended Dec. 31, 2022. While that comes in 21% ahead of totals from the same quarter last year, it falls short of analysts’ projections of $5.8 […]

Filed Under: Business/Financial News, MassDevice Earnings Roundup, Neurological, Wall Street Beat Tagged With: ClearPoint Neuro

ClearPoint Neuro to commercialize FDA-cleared neuro laser

September 23, 2022 By Chris Newmarker

ClearPoint Neuro (Nasdaq: CLPT) announced today that the FDA has cleared its Swedish partner Clinical Laserthermia Systems’ neuro laser therapy system. The plan is for ClearPoint Neuro to commercialize the system as the ClearPoint Prism. The company has exclusive global rights to commercialize the CLS magnetic resonance (MR) guided laser interstitial thermal therapy (MRgLITT) system. […]

Filed Under: 510(k), Featured, Food & Drug Administration (FDA), Imaging, Neurological, News Well, Regulatory/Compliance, Surgical Tagged With: ClearPoint Neuro, Clinical Laserthermia Systems

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy